Profile: Anamar Medical Ab develops biomarkers and offers treatments for chronic joint diseases. We focus on disease-modifying and anti-rheumatic drugs. Our AMAP102 is an orally available compound for the treatment of rheumatoid arthritis, originated from AnaMars proprietary 5-HT2 antagonists. The concept of using a 5-HT2 antagonist is for the treatment of the inflammatory component in arthritis and inflammatory pain. It provides a novel alternative to the established rheumatoid arthritis therapies. Our biomarkers clearly describe pathogenesis in chronic joint diseases, and are able to diagnose arthritis & establish a prognosis of the outcome for patients with chronic joint disease. They measure normal biologic, pathogenic or pharmacologic response to a preventive or therapeutic intervention.
11 Products/Services (Click for related suppliers)
|
• Chronic Total Occlusion Devices |
• Drug Delivery System |
• Drug Delivery System Development |
• Drug Wound Dressing (FDA Code: FRO) |
• Expendable Topical Products |
• Immunoassay Systems |
• Immunoassays |
• Protein Fractionation Densitometric Test (FDA Code: JQJ / 862.1630) A protein (fractionation) test system is a device intended to measure protein fractions in blood, urine, cerebrospinal fluid, and other body fluids. Protein fractionations are used as an aid in recognizing abnormal proteins in body fluids and genetic variants of proteins produced in diseases with tissue destruction. |
• Rheumatoid Arthritis Treatment |
• Sepsis Inflammatory Response Marker Antigen (FDA Code: NTM / 866.3210) An endotoxin assay is a device that uses serological techniques in whole blood. The device is intended for use in conjunction with other laboratory findings and clinical assessment of the patient to aid in the risk assessment of critically ill patients for progression to severe sepsis. |
• Spinal Cord Injury Course |